Annual report
4885.TEDINET S100P2VN
Period2021-06-01 → 2022-05-31
Filed2022-08-26
StandardJapan GAAP
ConsolidatedNo
Data checks13 of 13 passed
Key figures · 96
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥5.7bn | 2021-06-01 → 2022-05-31 | Standalone | Net sales |
| Revenue | ¥4.9bn | 2020-06-01 → 2021-05-31 | Standalone | Net sales |
| Revenue | ¥5.3bn | 2019-06-01 → 2020-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.4bn | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥5.4bn | 2018-06-01 → 2019-05-31d | Standalone | Net sales (5-year summary) |
| Revenue | ¥4.5bn | 2017-06-01 → 2018-05-31d | Standalone | Net sales (5-year summary) |
| Operating income | ¥437m | 2021-06-01 → 2022-05-31 | Standalone | Operating income |
| Operating income | ¥369m | 2020-06-01 → 2021-05-31 | Standalone | Operating income |
| Ordinary income | ¥423m | 2021-06-01 → 2022-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥339m | 2020-06-01 → 2021-05-31 | Standalone | Ordinary income |
| Ordinary income | ¥272m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥278m | 2019-06-01 → 2020-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥91m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥108m | 2018-06-01 → 2019-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | −¥20m | 2017-06-01 → 2018-05-31d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥426m | 2021-06-01 → 2022-05-31 | Standalone | Income before income taxes |
| Profit before tax | ¥200m | 2020-06-01 → 2021-05-31 | Standalone | Income before income taxes |
| Net income (owners) | ¥32m | 2019-06-01 → 2020-05-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥29m | 2018-06-01 → 2019-05-31d | Standalone | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥456m | 2021-06-01 → 2022-05-31 | Standalone | Profit loss |
| Net income | ¥181m | 2020-06-01 → 2021-05-31 | Standalone | Profit loss |
| Net income | ¥34m | 2019-06-01 → 2020-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | ¥112m | 2018-06-01 → 2019-05-31d | Standalone | Net income loss (5-year summary) |
| Net income | −¥88m | 2017-06-01 → 2018-05-31d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥4.8bn | at 2022-05-31 | Standalone | Assets |
| Total assets | ¥4.6bn | at 2021-05-31 | Standalone | Assets |
| Total assets | ¥4.8bn | at 2020-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.6bn | at 2019-05-31d | Standalone | Total assets (5-year summary) |
| Total assets | ¥4.7bn | at 2018-05-31d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥3.1bn | at 2022-05-31 | Standalone | Liabilities |
| Total liabilities | ¥3.3bn | at 2021-05-31 | Standalone | Liabilities |
| Net assets / equity | ¥1.7bn | at 2022-05-31 | Standalone | Net assets |
| Net assets / equity | ¥1.3bn | at 2021-05-31 | Standalone | Net assets |
| Net assets / equity | ¥252m | at 2020-05-31d | Standalone | Net assets |
| Net assets / equity | ¥182m | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥179m | at 2019-05-31d | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥71m | at 2018-05-31d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥865m | at 2022-05-31 | Standalone | Cash and deposits |
| Cash and deposits | ¥1.0bn | at 2021-05-31 | Standalone | Cash and deposits |
| Cash & equivalents | ¥865m | at 2022-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥1.0bn | at 2021-05-31 | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥881m | at 2020-05-31d | Standalone | Cash and cash equivalents |
| Cash & equivalents | ¥614m | at 2019-05-31d | Standalone | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥525m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥488m | 2020-06-01 → 2021-05-31 | Standalone | Net cash provided by used in operating activities |
| Operating cash flow | ¥89m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥342m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥176m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | −¥58m | 2020-06-01 → 2021-05-31 | Standalone | Net cash provided by used in investment activities |
| Investing cash flow | ¥137m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥311m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | −¥484m | 2021-06-01 → 2022-05-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | −¥311m | 2020-06-01 → 2021-05-31 | Standalone | Net cash provided by used in financing activities |
| Financing cash flow | ¥42m | 2019-06-01 → 2020-05-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥23m | 2018-06-01 → 2019-05-31d | Standalone | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥123.79 | 2021-06-01 → 2022-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥65.24 | 2020-06-01 → 2021-05-31 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.75 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.16 | 2019-06-01 → 2020-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.46 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥55.99 | 2018-06-01 → 2019-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-219.58 | 2017-06-01 → 2018-05-31d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥112.56 | 2021-06-01 → 2022-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥56.97 | 2020-06-01 → 2021-05-31 | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥19 | 2021-06-01 → 2022-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥15 | 2020-06-01 → 2021-05-31 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2019-06-01 → 2020-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2018-06-01 → 2019-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥3 | 2017-06-01 → 2018-05-31d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥450.37 | at 2022-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥363.93 | at 2021-05-31 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥101.92 | at 2020-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥91.2 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥89.32 | at 2019-05-31d | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥178.52 | at 2018-05-31d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.0% | at 2022-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 28.9% | at 2021-05-31 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 5.3% | at 2020-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 3.9% | at 2019-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 1.5% | at 2018-05-31d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 30.3% | 2021-06-01 → 2022-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 22.8% | 2020-06-01 → 2021-05-31 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.0% | 2019-06-01 → 2020-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 16.9% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| ROE | 89.6% | 2018-06-01 → 2019-05-31d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 4,095,500 | at 2022-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 4,095,500 | at 2021-05-31 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 775,000 | at 2020-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,010,000 | at 2019-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 1,010,000 | at 2018-05-31d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 197 | at 2022-05-31 | Standalone | Number of employees |
| Employees | 195 | at 2021-05-31 | Standalone | Number of employees |
| Employees | 196 | at 2020-05-31d | Standalone | Number of employees |
| Employees | 199 | at 2019-05-31d | Standalone | Number of employees |
| Employees | 199 | at 2018-05-31d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 53
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment assets | at 2022-05-31 | ¥1.3bn |
| Chemical Products Businessreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥39m |
| Chemical Products Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥55m |
| Chemical Products Businessreportable segment | employees | at 2022-05-31 | 50 pure |
| Chemical Products Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥1.9bn |
| Chemical Products Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥1.9bn |
| Chemical Products Businessreportable segment | segment assets | at 2022-05-31 | ¥1.2bn |
| Chemical Products Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | −¥16m |
| Healthy Food Businessreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥116m |
| Healthy Food Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥11m |
| Healthy Food Businessreportable segment | employees | at 2022-05-31 | 27 pure |
| Healthy Food Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥824m |
| Healthy Food Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥824m |
| Healthy Food Businessreportable segment | segment assets | at 2022-05-31 | ¥399m |
| Healthy Food Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥1m |
| Pharmaceutical Businessreportable segment | capex | 2021-06-01 → 2022-05-31 | ¥58m |
| Pharmaceutical Businessreportable segment | depreciation | 2021-06-01 → 2022-05-31 | ¥36m |
| Pharmaceutical Businessreportable segment | employees | at 2022-05-31 | 44 pure |
| Pharmaceutical Businessreportable segment | revenue | 2021-06-01 → 2022-05-31 | ¥2.9bn |
| Pharmaceutical Businessreportable segment | revenue external | 2021-06-01 → 2022-05-31 | ¥2.9bn |
| Pharmaceutical Businessreportable segment | segment assets | at 2022-05-31 | ¥2.0bn |
| Pharmaceutical Businessreportable segment | segment profit | 2021-06-01 → 2022-05-31 | ¥452m |
| Total Of Reportable Segments And Otherssegment total | capex | 2021-06-01 → 2022-05-31 | ¥213m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2021-06-01 → 2022-05-31 | ¥101m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-06-01 → 2022-05-31 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-06-01 → 2022-05-31 | ¥5.7bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2022-05-31 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-06-01 → 2022-05-31 | ¥437m |
| Reconciling Itemsreconciling | segment assets | at 2021-05-31 | ¥1.3bn |
| Chemical Products Businessreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥15m |
| Chemical Products Businessreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥67m |
| Chemical Products Businessreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥1.7bn |
| Chemical Products Businessreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥1.7bn |
| Chemical Products Businessreportable segment | segment assets | at 2021-05-31 | ¥1.2bn |
| Chemical Products Businessreportable segment | segment profit | 2020-06-01 → 2021-05-31 | −¥61m |
| Healthy Food Businessreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥4m |
| Healthy Food Businessreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥22m |
| Healthy Food Businessreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥800m |
| Healthy Food Businessreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥800m |
| Healthy Food Businessreportable segment | segment assets | at 2021-05-31 | ¥376m |
| Healthy Food Businessreportable segment | segment profit | 2020-06-01 → 2021-05-31 | −¥44m |
| Pharmaceutical Businessreportable segment | capex | 2020-06-01 → 2021-05-31 | ¥16m |
| Pharmaceutical Businessreportable segment | depreciation | 2020-06-01 → 2021-05-31 | ¥35m |
| Pharmaceutical Businessreportable segment | revenue | 2020-06-01 → 2021-05-31 | ¥2.5bn |
| Pharmaceutical Businessreportable segment | revenue external | 2020-06-01 → 2021-05-31 | ¥2.5bn |
| Pharmaceutical Businessreportable segment | segment assets | at 2021-05-31 | ¥1.7bn |
| Pharmaceutical Businessreportable segment | segment profit | 2020-06-01 → 2021-05-31 | ¥475m |
| Total Of Reportable Segments And Otherssegment total | capex | 2020-06-01 → 2021-05-31 | ¥35m |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2020-06-01 → 2021-05-31 | ¥124m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2020-06-01 → 2021-05-31 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2020-06-01 → 2021-05-31 | ¥4.9bn |
| Total Of Reportable Segments And Otherssegment total | segment assets | at 2021-05-31 | ¥3.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2020-06-01 → 2021-05-31 | ¥369m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,194
| Item | Context | Value | Unit |
|---|---|---|---|
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Research and development activities (text) | FilingDateInstant | Text · Plus | |
| Overview of capital expenditures etc (text) | FilingDateInstant | Text · Plus | |
| Major facilities (text) | FilingDateInstant | Text · Plus | |
| Planned additions retirements etc of facilities (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所スタンダード | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Text · Plus | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Description of rights plan (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus | |
| Shareholding by shareholder category (text) | FilingDateInstant | Text · Plus | |
| Major shareholders (text) | FilingDateInstant | Text · Plus | |
| Name major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)村山 哲朗 | |
| Address major shareholders | CurrentYearInstant_No1MajorShareholdersMember | Original text (Japanese)長野県北佐久郡軽井沢町 | |
| Name major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)青木 淳一 | |
| Address major shareholders | CurrentYearInstant_No2MajorShareholdersMember | Original text (Japanese)群馬県太田市 | |
| Name major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)室町ケミカルグループ従業員持株会 | |
| Address major shareholders | CurrentYearInstant_No3MajorShareholdersMember | Original text (Japanese)福岡県大牟田市新勝立町1丁目38番5 | |
| Name major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)服部 英法 | |
| Address major shareholders | CurrentYearInstant_No4MajorShareholdersMember | Original text (Japanese)佐賀県佐賀市 | |
| Name major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)室町機械株式会社 | |
| Address major shareholders | CurrentYearInstant_No5MajorShareholdersMember | Original text (Japanese)東京都中央区日本橋室町4丁目2-1 | |
| Name major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)髙宮 一仁 | |
| Address major shareholders | CurrentYearInstant_No6MajorShareholdersMember | Original text (Japanese)埼玉県蕨市 | |
| Name major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)大辻 正高 | |
| Address major shareholders | CurrentYearInstant_No7MajorShareholdersMember | Original text (Japanese)埼玉県さいたま市大宮区 | |
| Name major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)穗苅 久美 | |
| Address major shareholders | CurrentYearInstant_No8MajorShareholdersMember | Original text (Japanese)東京都杉並区 | |
| Name major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)井内 聡 | |
| Address major shareholders | CurrentYearInstant_No9MajorShareholdersMember | Original text (Japanese)福岡県大牟田市 | |
| Name major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)荒井 敏雄 | |
| Address major shareholders | CurrentYearInstant_No10MajorShareholdersMember | Original text (Japanese)東京都文京区 | |
| Issued shares voting rights (text) | FilingDateInstant | Text · Plus | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithNoVotingRightsMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Description issued shares voting rights | CurrentYearInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesTreasurySharesSharesWithFullVotingRightsTreasurySharesEtcMember | Original text (Japanese)権利内容に何ら限定のない当社における標準となる株式であります。なお、単元株式数は100株であります。 | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | Original text (Japanese)同上 | |
| Description issued shares voting rights | CurrentYearInstant_OrdinarySharesSharesLessThanOneUnitMember | － |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 13 of 13 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |